advertising
-
1
Burzykowski G, Molenberghs D, Abeck E, et al: High prevalence of foot diseases in Europe: results of the Achilles project. .Mycoses 46::496. ,2003. .
-
2
Lubeck D, Patrick D, McNulty P, et al: Quality of life of persons with onychomycosis. .Qual Life Res 2::341. ,1993. .
-
3
Elewski B: The effect of toenail onychomycosis on patient quality of life. .Int J Dermatol 36::754. ,1997. .
-
4
Roberts D: Onychomycosis: current treatment and future challenges. .Br J Dermatol 141: (suppl 56):1. ,1999. .
-
5
Olafsson JH, Sigurgeirsson B, Baran R: Combination therapy for onychomycosis. .Br J Dermatol 149: (suppl 65):15. ,2003. .
-
6
Medoff G, Kobayashi G, Kwang C: Potentialisation of rifampicin and fluorocytosine as antifungal antibiotics by amphotericin B. .Proc Soc Exp Biol Med 138::571. ,1971. .
-
7
Polak A: The past, present and future of antimycotic combination therapy. .Mycoses 42::355. ,1999. .
-
8
Evans EGV: The rationale for combination therapy. .Br J Dermatol 145: (suppl 60):9. ,2001. .
-
9
Hay R, Clayton Y, Moore M: A comparison of tioconazole 28% nail solution versus base as an adjunct to oral griseofulvin in patients with onychomycosis. .Clin Exp Dermatol 12::175. ,1987. .
-
10
Nolting S: “Open Studies of Ciclopirox Nail Lacquer in Onychomycosis: A Review,” in Hydroxy-Pyridones as Antifungal Agents with Special Emphasis on Onychomycosis, ed by S Shuster, p 75, Springer-Verlag, Berlin. ,1999. .
-
11
Gupta AK, Kohli Y: In vitro susceptibility testing of ciclopirox, terbinafine, ketoconazole and itraconazole against dermatophytes and nondermatophytes, and in vitro evaluation of combination antifungal activity. .Br J Dermatol 149::296. ,2003. .
-
12
Baran R, Bohn M, Kraemer K, et al: Characterisation of interactions between systemic and topical antifungal agents. Poster presented at the American Academy of Dermatology 59th Annual Meeting, March 2–7. ,2001. , Washington, DC.
-
13
Lauharanta J, Zaug M, Polak A, et al: Combination of amorolfine with griseofulvin: in vitro activity and clinical results in onychomycosis. .JAMA (SEA) 9: (suppl 4):23. ,1993. .
-
14
Zaug M: Amorolfine nail lacquer: clinical experience in onychomycosis. .J Eur Acad Dermatol Venereol 4: (suppl 1) :S23. ,1995. .
-
15
Baran R, Feulhade M, Datry A, et al: A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the nail region. .Br J Dermatol 142::1177. ,2000. .
-
16
Szepietowski J, Roiycka B: Combined therapy for onychomycosis. .Mikol Lek 8::47. ,2001. .
-
17
Baran E, Bochenski J: Combined approach to onychomycosis management (abstract SP5-1). .J Eur Acad Dermatol Venereol 17: (suppl 1):40. ,2003. .
-
18
Baran E, Bochenski J, Duczkowski M, et al: Combination therapy for onychomycosis with amorolfine nail lacquer and oral antifungal agents. .Mikol Lek 10::79. ,2003. .
-
19
Lecha M, Alsina M, Torres M, et al: Amorolfine and itraconazole combination for severe toenail onychomycosis: results of an open randomised trial in Spain. .Br J Dermatol 145: (suppl 60):21. ,2001. .
-
20
Maleszka R, Ratajczak V, Turek-Krasinska K, et al: The use of amorolfine in the treatment of dermatophyte onychomycosis. .Prz Dermatol 89::493. ,2002. .
-
21
Adaskevich U, Evseenko I: Itraconazole in combined treatment of patients with onychomycosis (abstract PP1-1). .J Eur Acad Dermatol Venereol 17: (suppl 1):47. ,2003. .
-
22
Sergeev Y, Sergeev A: Pulsed combination therapy: the new option for onychomycosis. .Mycoses 44: (suppl 1):68. ,2001. .
-
23
Sergeev A, Sergeev Y: Combined treatment of onychomycosis with fluconazole and amorolfine nail lacquer [abstract]. In Proceedings of the Fourth Congress of the European Confederation of Medical Mycology, Glasgow. ,1998. .
-
24
Roberts DT, Evans EG: Subungual dermatophytoma complicating dermatophyte onychomycosis. .Br J Dermatol 138::189. ,1998. .
-
25
Seebacher C: Action mechanisms of modern antifungal agents and resulting problems in the management of onychomycosis. .Mycoses 46::506. ,2003. .
-
26
Hargreaves G: The treatment of onychomycosis with griseofulvin. .Br J Dermatol 72::358. ,1960. .
-
27
White MI, Clayton YM: The treatment of fungus and yeast infections of the nail by the method of “chemical removal.”. Clin Exp Dermatol 7::273. ,1982. .
-
28
Baran R, Hay RJ: Partial surgical avulsion of the nail in onychomycosis. .Clin Exp Dermatol 10::413. ,1985. .
-
29
Baran R: Nail fungal infections and treatment. .Hand Clin 18::625. ,2002. .
-
30
South D, Farber E: Urea ointment in the non-surgical avulsion of nail dystrophies: a reappraisal. .Cutis 25::609. ,1980. .
-
31
Roberts DT, Taylor WD, Boyle J: Guidelines for treatment of onychomycosis. .Br J Dermatol 148::402. ,2003. .
-
32
Murray SC, Dawber RPR: Onychomycosis of the toenails: podiatric and orthopaedic considerations. .Australas J Dermatol 43::105. ,2002. .
-
33
Scher R, Baran R: Onychomycosis in clinical practice: factors contributing to recurrence. .Br J Dermatol 149: (suppl 65):5. ,2003. .
-
34
Zaias N, Rebell G: Chronic dermatophytosis syndrome due to Trichophyton rubrum.. Int J Dermatol 35::614. ,1996. .
-
35
Gupta AK, Baran R: Ciclopirox nail lacquer solution 8% in the 21st century. .J Am Acad Dermatol 43::S96. ,2000. .
Topical and Oral Combination Therapy for Toenail Onychomycosis
An Updated Review
Search for other papers by Ivan R. Bristow in
Current site
Google Scholar
PubMed
Search for other papers by Robert Baran in
Current site
Google Scholar
PubMed
Although effective, oral antifungal therapy is still not completely successful. Recent studies have shown that combination therapy with oral and topical agents offers an increased cure rate for patients. We review the main drug combinations that have been tested. Additional measures, such as mechanical intervention, may help improve response rates further. (J Am Podiatr Med Assoc 96(2): 116–119, 2006)
advertising
